Pharma future & health

Business

Bye bye resilience

The reshoring of pharmaceutical production to the United States sheds an even darker light on the long-standing issue of the fragility of the European pharmaceutical supply chain. Chiedi a ChatGPT

A matter of trust

Life Science M&A

BIODRUGS & ATMP

Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing

A new amendment of the previous agreement introduces an exclusive GMP suite at the AGC Biologics Cell and Gene Center of Excellence in Milan, dedicated to the manufacturing of Genenta’s cell therapy product

ONE HEALTH

One Health and AMR: the new global agenda

The WHO draft Global Action Plan 2026–2036 reinforces the One Health approach to antimicrobial resistance. Between global governance, equitable access, and incentives for antibiotic innovation, the new health agenda is set to have direct implications for pharmaceutical industry strategies.

Seguici sui social

16,985FansLike
2,458FollowersFollow
61,453SubscribersSubscribe
spot_img
spot_img
spot_img
spot_img
spot_img
spot_img